1-3 of 3
John F. Timms
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population

Oleg Blyuss, Matthew Burnell, Andy Ryan, Aleksandra Gentry-Maharaj, Inés P. Mariño, Jatinderpal Kalsi, Ranjit Manchanda, John F. Timms, Mahesh Parmar, Steven J. Skates, Ian Jacobs, Alexey Zaikin, Usha Menon
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (19): 4726–4733.
https://doi.org/10.1158/1078-0432.CCR-18-0208
Published: 01 October 2018
View article titled, Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population
Open the PDF for Comparison of Longitudinal CA125 Algorithms as a First-Line Screen for Ovarian Cancer in the General Population in another window
Includes: Supplementary data
Journal Articles

Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus

Claire Jenkinson, Victoria L. Elliott, Anthony Evans, Lucy Oldfield, Rosalind E. Jenkins, Darragh P. O'Brien, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Evangelia-O Fourkala, Ian J. Jacobs, Usha Menon, Trevor Cox, Fiona Campbell, Stephen P. Pereira, David A. Tuveson, B. Kevin Park, William Greenhalf, Robert Sutton, John F. Timms, John P. Neoptolemos, Eithne Costello
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (7): 1734–1743.
https://doi.org/10.1158/1078-0432.CCR-15-0879
Published: 31 March 2016
View article titled, Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus
Open the PDF for Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus in another window
Includes: Supplementary data
Journal Articles

Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection

Darragh P. O'Brien, Neomal S. Sandanayake, Claire Jenkinson, Aleksandra Gentry-Maharaj, Sophia Apostolidou, Evangelia-Ourania Fourkala, Stephane Camuzeaux, Oleg Blyuss, Richard Gunu, Anne Dawnay, Alexey Zaikin, Ross C. Smith, Ian J. Jacobs, Usha Menon, Eithne Costello, Stephen P. Pereira, John F. Timms
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (3): 622–631.
https://doi.org/10.1158/1078-0432.CCR-14-0365
Published: 01 February 2015
View article titled, Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection
Open the PDF for Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection in another window
Includes: Supplementary data